Bridger Management »

Bausch Lomb Corp shares owned by Bridger Management

Quarter-by-quarter ownership of Bausch Lomb Corp (BLCO) shares owned by Bridger Management from 13F filings

Historical chart of Bridger Management investment in Bausch Lomb Corp

Tip: Access up to 7 years of quarterly data

All positions including Bausch Lomb Corp held by Bridger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bausch Lomb Corp by Bridger Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.4M 506k 14.52
2023-09-30 $4.2M 245k 16.95
2023-06-30 $4.9M 245k 20.07

More positions owned by Bridger Management

Eli Lilly & Co. (LLY)
Uber Technologies (UBER)
Vertex Pharmaceuticals Incorporated (VRTX)
Morgan Stanley Com New (MS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Pfizer (PFE)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alnylam Pharmaceuticals (ALNY)
Bath &#38 Body Works In (BBWI)
Bausch Plus Lomb Corp Common Shares (BLCO)
Melco Resorts And Entmnt Adr (MLCO)
Caesars Entertainment (CZR)
Xenon Pharmaceuticals (XENE)
Geron Corporation (GERN)
Springworks Therapeutics (SWTX)

View all positions for Bridger Management

Top funds holding Bausch Lomb Corp

GoldenTree Asset Management
Maple Rock Capital Partners
Carl C. Icahn, Individual
Alberta Investment Management Corporation
River Road Asset Management
D. E. Shaw & Co
Apollo Management Holdings
Nomura Holdings
Whitebox Advisors
Empyrean Capital Partners
Laurion Capital Management
ExodusPoint Capital Management
Canada Pension Plan Investment Board
Arrowstreet Capital, Limited Partnership
King Street Capital Management

View all funds holding Bausch Lomb Corp